chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Cough, Headache, Nasal discomfort
Clinical narrative: a low grade fever (99F-100F); slight headache; "cold symptoms"; coughing; sneezing; blowing her nose; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 25Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. About a week later, she reported a low grade fever (99F-100F) along with a slight headache and "cold symptoms" including: coughing, sneezing, and blowing her nose. She went for a rapid covid test 9 days after vaccination, which was positive, and she's waiting on an additional covid test that was sent to the lab. The outcome of events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia, SARS-CoV-2 test, Sneezing
Clinical narrative: a low grade fever (99F-100F); slight headache; "cold symptoms"; coughing; sneezing; blowing her nose; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 25Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. About a week later, she reported a low grade fever (99F-100F) along with a slight headache and "cold symptoms" including: coughing, sneezing, and blowing her nose. She went for a rapid covid test 9 days after vaccination, which was positive, and she's waiting on an additional covid test that was sent to the lab. The outcome of events was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Oropharyngeal discomfort, Sensation of foreign body, Swelling face, Visual impairment
Clinical narrative: gained about 3 pounds now; The next day, her cheeks, face, and the part under her chin became swollen/her body also became swollen; she feels something in her throat which she can't describe; she feels something in her throat which she can't describe; her vision on her good eye became a little depleted; inside of her lips was swollen; This is a spontaneous report from a contactable consumer. This 81-year-old Female consumer reported for herself that she received the first dose of (PFIZER-BIONTECH COVID-19 VACCINE, Lot number unknown) at single dose on 27Jan2021 for COVID-19 immunisation. Relevant history included food allergy. Relevant concomitant drug was unknown. The patient received her 1st dose on 27Jan2021 and stated that she was feeling fine for about 10 minutes and when she got back home which was not very far from the vaccination site, she noticed that the inside of her lips was swollen. She mentioned that this was not strange for her since she was mostly allergic to food but usually it was the outer portion of her lips that became swollen and not the inner portion. The next day, her cheeks, face, and the part under her chin became swollen and she felt something in her throat which she could describe. She also noticed that her vision on her good eye became a little depleted which got her a little concerned and her body also became swollen and stated that she already gained about 3 pounds now. She wanted to know if anyone had reported the same reaction she had and if it was recommended for her to get the 2nd dose or not. Outcome of events was unknown.  The information on the LOT/Batch number has been requested
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Weight, Weight increased
Clinical narrative: gained about 3 pounds now; The next day, her cheeks, face, and the part under her chin became swollen/her body also became swollen; she feels something in her throat which she can't describe; she feels something in her throat which she can't describe; her vision on her good eye became a little depleted; inside of her lips was swollen; This is a spontaneous report from a contactable consumer. This 81-year-old Female consumer reported for herself that she received the first dose of (PFIZER-BIONTECH COVID-19 VACCINE, Lot number unknown) at single dose on 27Jan2021 for COVID-19 immunisation. Relevant history included food allergy. Relevant concomitant drug was unknown. The patient received her 1st dose on 27Jan2021 and stated that she was feeling fine for about 10 minutes and when she got back home which was not very far from the vaccination site, she noticed that the inside of her lips was swollen. She mentioned that this was not strange for her since she was mostly allergic to food but usually it was the outer portion of her lips that became swollen and not the inner portion. The next day, her cheeks, face, and the part under her chin became swollen and she felt something in her throat which she could describe. She also noticed that her vision on her good eye became a little depleted which got her a little concerned and her body also became swollen and stated that she already gained about 3 pounds now. She wanted to know if anyone had reported the same reaction she had and if it was recommended for her to get the 2nd dose or not. Outcome of events was unknown.  The information on the LOT/Batch number has been requested
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Chills, Headache, Middle insomnia
Clinical narrative: body aches; chills; my back started aching; feeling feverish but no fever; felt like a headache was coming on/was going to get a headache; her arm hurt/arm pain/iced the injection site; never falling back asleep; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Feb2021 15:15 at single dose for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient previously received first dose of BNT162B2 on 12Jan2021 for COVID-19 immunization. After 2nd vaccine. The patient felt fine most of the evening and through the night. The patient woke up in the middle of the night around 3/3:30 am (totally normal for her) and felt fine except for some arm pain on 05Feb2021. The patient iced the injection site, but by 4:30/5 the patient was still awake and now felt like she was going to get a headache (also common for patient). The patient took her temperature (was normal), took 2 Tylenol (5am), and went back to bed (but never falling back asleep). The patient left for work at 6:45am. The patient felt totally fine, even energetic, most of the morning. The following day at 10 am caller reported body aches and feeling feverish but no fever. At almost 10am exactly, her back started aching and by 10:30 the patient had full body aches and started getting chills. The patient left work at 11am, was home before 12pm with a temperature of 98.5, took 2 more Tylenol and napped. The patient had no symptoms the rest of the afternoon until 5pm when the back aches returned. Took 2 more Tylenol. The patient napped later in the evening, too, but took 2 more Tylenol at 10pm before going to sleep for the night. Woke up Saturday morning without symptoms. The outcome of events was recovered in Feb2021.  Information about Lot/batch number requested.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site pain
Clinical narrative: body aches; chills; my back started aching; feeling feverish but no fever; felt like a headache was coming on/was going to get a headache; her arm hurt/arm pain/iced the injection site; never falling back asleep; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Feb2021 15:15 at single dose for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient previously received first dose of BNT162B2 on 12Jan2021 for COVID-19 immunization. After 2nd vaccine. The patient felt fine most of the evening and through the night. The patient woke up in the middle of the night around 3/3:30 am (totally normal for her) and felt fine except for some arm pain on 05Feb2021. The patient iced the injection site, but by 4:30/5 the patient was still awake and now felt like she was going to get a headache (also common for patient). The patient took her temperature (was normal), took 2 Tylenol (5am), and went back to bed (but never falling back asleep). The patient left for work at 6:45am. The patient felt totally fine, even energetic, most of the morning. The following day at 10 am caller reported body aches and feeling feverish but no fever. At almost 10am exactly, her back started aching and by 10:30 the patient had full body aches and started getting chills. The patient left work at 11am, was home before 12pm with a temperature of 98.5, took 2 more Tylenol and napped. The patient had no symptoms the rest of the afternoon until 5pm when the back aches returned. Took 2 more Tylenol. The patient napped later in the evening, too, but took 2 more Tylenol at 10pm before going to sleep for the night. Woke up Saturday morning without symptoms. The outcome of events was recovered in Feb2021.  Information about Lot/batch number requested.
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: UTI; This is a spontaneous report from a Pfizer sponsored program. A contactable female consumer (patient) of an unspecified age reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced UTI (urinary tract infection) on an unspecified date with outcome of unknown. She was currently on antibiotics due to the UTI and wanted to know if that would effect the 2nd dose of the vaccine she was scheduled to get the 2nd dose next Friday 12Feb2021.  Information on the Lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: She reports the rash started on her upper body; This is a spontaneous report from a contactable consumer (patient). A female patient of unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 05Feb2021 14:00 at single dose in arm for COVID-19 immunization. Medical history included allergic to sulfa drugs. Concomitant medication included BP medications. The patient received her first dose of Pfizer-Biontech Covid19 vaccine, yesterday 05Feb2021 around 2pm. She reported an all-over body rash that woke her up at 3am which she treated with a ointment that she had "and that helped". She reported the rash started on her upper body, but now radiated all the way down her buttocks and legs. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia, Vomiting
Clinical narrative: Headache; fever; chills; nausea; vomiting; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 03Feb2021 15:45 at single dose in left arm for COVID-19 immunization. Medical history included allergies to Zithromax. Concomitant medication included topiramate. The patient previously received first dose of BNT162B2 on 13Jan2021 03:45 PM in left arm. The patient had no covid prior vaccination. The patient had no covid tested post vaccination. The patient experienced Headache, fever, chills, nausea, vomiting. Headache began about 2 hours after 2nd dosage administered (03Feb2021 17:45). Rest of symptoms began about 12 hours after headache. Vomiting, fever, chills and nausea all lasted about 8 to 10 hours. Headache lasted about 24 hour. No treatment was received for the events. The outcome of all events was resolved on 04Feb2021.  Information about lot/batch has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Oral discomfort, Oral herpes, Stress
Clinical narrative: stress; She has a cold sore; a little puffy around her lip; This is a spontaneous report from a contactable consumer reporting for self via Pfizer sponsored program. A female patient of an unspecified age (age: 92 or 79, unit: unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Feb2021 at single dose for covid-19 immunisation. Patient received the first dose on unknown date. The patient medical history was not reported. The patient's concomitant medications were not reported.  Patient has a cold sore that started coming on a few days ago. It didn't come out yet but it has been a little puffy around her lip starting 3-4 days ago. She stated, with all the stress from the whole year her resistance is probably low but it has nothing to do with the vaccine. She definitely knows it is from all the stress going on. She stated she had relatively no effects from either dose. She asked if it is okay to take Valacyclovir for the cold sore. After verbal response provided, she stated she probably will err on being conservative and not take it. She wanted to take Valaciclovir (for herpes) but she don't want to do anything since she waited so long for the vaccine and she would like to ask if it is okay to take another medication after her 2nd shot. Outcome of events was unknown.   Information about lot/batch number has been requested.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pruritus, Urticaria
Clinical narrative: Appear to be either Shingles or hives, itchy spots on neck face and scalp; Appear to be either Shingles or hives, itchy spots on neck face and scalp; Appear to be either Shingles or hives, itchy spots on neck face and scalp; This is a spontaneous report from a contactable consumer (patient). A 46-years-old female patient received dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number EL9265), via an unspecified route of administration in left arm on 05Feb2021 10:30 at single dose for COVID-19 immunization. Medical history included Allergic to shellfish, Allergic to soy, Mould allergy, pollen allergies, Atopic dermatitis. There were no concomitant medications. The patient previously took dupilumab (DUPIXENT) from unknown date to 20Dec2020 for Atopic dermatitis. The patient experienced appear to be either shingles or hives, itchy spots on neck face and scalp on 06Feb2021 06:00. Treatment received for the events included Desoxymetasone steroid applied without any effect. The patient was not pregnant. The patient had no COVID prior vaccination. She had no COVID tested post vaccination. There was no other vaccine received at the same date of the COVID-19 vaccine. There was no other vaccine received in four weeks. The outcome of the events was not recovered.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Covid vaccine given, 4 days later infected with Covid; This is a spontaneous report from a contactable Physician. A male patient of an unspecified age received bnt162b2 (BNT162B2) first dose, via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient's medical history  and concomitant medications were not reported. The patient experienced covid vaccine given, 4 days later infected with covid on an unspecified date with outcome of unknown.Reported Question: Covid vaccine given, 4 days later infected with Covid. He was treated with Bamlanivimab 1 week after vaccine. Should this patient got both doses of vaccine in 3 months?  Information about Lot/ Batch has been requested.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Feeling cold, Reaction to excipient, Tremor
Clinical narrative: extremely cold and she thought it's because of the PEG within it; I'm extremely cold/freeze to death; Shaky; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Medical history included high blood pressure and it hadn't been this high in a quiet a few years, colonoscopy. The patient's concomitant medications were not reported. The patient was extremely cold and she thought it's because of the PEG within it. PEG is one of excipients of BNT162B2. Last year, when the patient had her colonoscopy done, they gave her Gavilyte and she frozen to death, walked like a frozen death person (Miralax/Gavilyte) It was for about a week. She stayed so cold. It took all her vitamins, that stuff was wicked. As she ate different foods that had the component in it. She felt better. The last one she ate was potato chips (eat very few). It was the salt, so she could eat more. The salt in the chips straightened her out. Gavilyte took the salt out of her system. The patient had to drink 12 Gatorades. It was making her fall. It's not the chills, she was cold from the inside out. It was worse than being cold from cleaning a walk in freezer. She was a "walking dead person" same cold. It's that bad. She had 3 outfits on, a cold and blankets. Never been that cold in her life and it was from Gavilyte. (After receiving the first dose of the Pfizer vaccine) She felt that away for about a week and now it's gone. It brought it all back, same feeling, freeze to death, shaky. The patient stated she would see her heart doctor. The outcome of events was unknown. On 17Feb2021 she's scheduled for the 2nd dose of BNT162B2.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: a little tired; her arm is a little sore; This is a spontaneous report from a contactable consumer (patient) from a Pfizer Sponsored Program. A 75-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the night of 05Feb2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was a little tired and her arm was a little sore on an unspecified date. The event outcome was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Pruritus
Clinical narrative: skin felt like itchy pinpricks all over; tiredness; dizziness/lightheadedness; This is a spontaneous report from a contactable Consumer (Patient). A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246), via an unspecified route of administration at left arm on an unknown date in Jan2021 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. Medical history included Chronic Sinusitis, patient's known allergies: Systemic steroids, Amoxicillin, Prednisone, Cortizone, Levofloxacin, Famotidine, Apples, Pineapples, Shellfish. Concomitant medication included hydrochlorothiazide, lisinopril (LISINOPRIL AND HYDROCHLOROTHIAZIDE), colecalciferol (D3), cyanocobalamin (VITAMIN B12). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Skin felt like itchy pinpricks all over, tiredness, dizziness and lightheadedness for about 2 days happened eight days after receiving first dose on an unknown date in Jan2021. Adverse event resulted in: Doctor or other healthcare professional office/clinic visit. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered on an unknown date.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Diarrhoea, Dizziness
Clinical narrative: joint pain; weakness; chills; diarrhea; dizziness; minor difficulty breathing; headache; Injection site pain; malaise; muscle cramping; swollen lymph nodes; projectile vomiting; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient (not pregnant) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EN9581) via an unspecified route of administration in right arm on 03Feb2021 15:45 at single dose for covid-19 immunisation.  Medical history included diabetes, hypertension (HTN), and gastrooesophageal reflux disease (GERD). Known allergies included xylometazoline hydrochloride (SUDAFED). Concomitant medication included omeprazole (PROTONIX), metformin hydrochloride, sitagliptin (JANUMET), empagliflozin (JARDIANCE), insulin glargine (BASAGLAR), escitalopram oxalate (LEXAPRO).  There was no other vaccine in four weeks. The patient had no COVID prior vaccination. The patient had no COVID tested post vaccination. The patient experienced joint pain, weakness, chills, diarrhea, dizziness, minor difficulty breathing, headache, injection site pain, malaise, muscle cramping, swollen lymph nodes, projectile vomiting, all on 04Feb2021 09:15 with outcome of recovering. No treatment received for the events.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Lymphadenopathy, Malaise, Muscle spasms
Clinical narrative: joint pain; weakness; chills; diarrhea; dizziness; minor difficulty breathing; headache; Injection site pain; malaise; muscle cramping; swollen lymph nodes; projectile vomiting; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient (not pregnant) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EN9581) via an unspecified route of administration in right arm on 03Feb2021 15:45 at single dose for covid-19 immunisation.  Medical history included diabetes, hypertension (HTN), and gastrooesophageal reflux disease (GERD). Known allergies included xylometazoline hydrochloride (SUDAFED). Concomitant medication included omeprazole (PROTONIX), metformin hydrochloride, sitagliptin (JANUMET), empagliflozin (JARDIANCE), insulin glargine (BASAGLAR), escitalopram oxalate (LEXAPRO).  There was no other vaccine in four weeks. The patient had no COVID prior vaccination. The patient had no COVID tested post vaccination. The patient experienced joint pain, weakness, chills, diarrhea, dizziness, minor difficulty breathing, headache, injection site pain, malaise, muscle cramping, swollen lymph nodes, projectile vomiting, all on 04Feb2021 09:15 with outcome of recovering. No treatment received for the events.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting projectile
Clinical narrative: joint pain; weakness; chills; diarrhea; dizziness; minor difficulty breathing; headache; Injection site pain; malaise; muscle cramping; swollen lymph nodes; projectile vomiting; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient (not pregnant) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EN9581) via an unspecified route of administration in right arm on 03Feb2021 15:45 at single dose for covid-19 immunisation.  Medical history included diabetes, hypertension (HTN), and gastrooesophageal reflux disease (GERD). Known allergies included xylometazoline hydrochloride (SUDAFED). Concomitant medication included omeprazole (PROTONIX), metformin hydrochloride, sitagliptin (JANUMET), empagliflozin (JARDIANCE), insulin glargine (BASAGLAR), escitalopram oxalate (LEXAPRO).  There was no other vaccine in four weeks. The patient had no COVID prior vaccination. The patient had no COVID tested post vaccination. The patient experienced joint pain, weakness, chills, diarrhea, dizziness, minor difficulty breathing, headache, injection site pain, malaise, muscle cramping, swollen lymph nodes, projectile vomiting, all on 04Feb2021 09:15 with outcome of recovering. No treatment received for the events.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Loss of personal independence in daily activities, Pain in extremity
Clinical narrative: Severe arm pain going down to hands and fingers.; could not unfold elbow or arm due to pain; She could not dress b/c the feeling of clothing in arm was excruciating.; This is a spontaneous report from a consumer (patient). A 75-year-old female patient received first dose of BNT162B2 (lot/batch number and expiration date were unknown) via an unspecified route of administration at left arm on 02Feb2021 08:00 at single dose for covid-19 vaccine. Medical history included diabetes and hypertension. Unspecified concomitant medication used in two weeks. There was no known allergies. There was no other vaccine in four weeks. Patient did not have COVID prior vaccination. The patient had severe arm pain going down to hands and fingers on 02Feb2021 at 18:00. She had severe sensitivity. She could sleep due to pain but could not unfold elbow or arm due to pain. She could not dress b/c the feeling of clothing in arm was excruciating. She was in tears. It was been about 5 days and the pain and sensitivity has increased every day. Patient had taken paracetamol (Tylenol), ibuprofen (Advil) went to my primary and got prescribed tramadol for pain. Nothing was helping. Patient visited doctor or other healthcare professional office/clinic visit due to events. She did not have COVID tested post vaccination. The outcome of events was not recovered.  Information on batch number has been requested.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on back and partially on chest; This is a spontaneous report from a contactable consumer (Patient). A 68-years-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 23Jan2021 14:00 at single dose at Left arm for covid-19 immunisation .  Medical history included type 1 diabetes mellitus.  Concomitant medication included insulin.  The patient experienced rash on back and partially on chest on 23Jan2021. This has persisted since vaccination date (23Jan2021) until 06Feb2021. Therapeutic measures were taken as a result of rash on back and partially on chest included Benadryl and Calamine. The outcome of event was not recovered. No other vaccine in four weeks; No covid prior vaccination; No covid tested post vaccination.    Information on lot/batch number has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral coldness
Clinical narrative: Left hand tingling and cold.; Left hand tingling and cold.; This is a spontaneous report from a contactable consumer (patient).  A 39-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number EL9264), via an unspecified route of administration in left arm on 06Feb2021 15:30 at single dose for COVID-19 immunisation. Medical history included asthma. She had no known allergies. Concomitant medication included beclometasone dipropionate (QVAR) and mometasone furoate (FLONASE). The patient experienced left hand tingling and cold on 06Feb2021 15:30. No treatment received for the events. The patient was not pregnant. The patient had no COVID prior vaccination. She had no COVID tested post vaccination. The outcome of the events was recovering.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Dizziness, Fatigue, Headache
Clinical narrative: received first dose on 27Dec2020 and second dose on 13Jan2021; received first dose on 27Dec2020 and second dose on 13Jan2021; chills; fever; dizziness; headache; nausea; lack of appetite; fatigue; hot flashes; This is a spontaneous report from a contactable nurse (patient). A 27-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176, ), intramuscular in the Left arm on 13Jan2021 13:30 PM at single dose for covid-19 immunisation. Patient was not pregnant. Medical history was None. No known allergies. No other medical history. No other vaccine in four weeks. Other medications in two weeks included Birth control. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EH9899, administrator route=Intramuscular, vaccine location=Left arm) on 27Dec2020 at age of 27 years old for COVID-19 immunization and nothing after the first shot. The night of the second shot (13Jan2021) patient had chills, fever, dizziness, headache, nausea, lack of appetite, fatigue, and hot flashes until the following two days (15Jan2021). Then dizziness, fatigue, nausea, lack of appetite, chills, and hot flashes for about a week (in Jan2021). No treatment for the adverse events. No covid prior vaccination. No covid tested post vaccination. The patient administered vaccine in Doctor's office/urgent care. The outcome of 'received first dose on 27dec2020 and second dose on 13jan2021' was unknown, of other events was recovered.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Inappropriate schedule of product administration, Nausea, Off label use, Pyrexia
Clinical narrative: received first dose on 27Dec2020 and second dose on 13Jan2021; received first dose on 27Dec2020 and second dose on 13Jan2021; chills; fever; dizziness; headache; nausea; lack of appetite; fatigue; hot flashes; This is a spontaneous report from a contactable nurse (patient). A 27-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176, ), intramuscular in the Left arm on 13Jan2021 13:30 PM at single dose for covid-19 immunisation. Patient was not pregnant. Medical history was None. No known allergies. No other medical history. No other vaccine in four weeks. Other medications in two weeks included Birth control. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EH9899, administrator route=Intramuscular, vaccine location=Left arm) on 27Dec2020 at age of 27 years old for COVID-19 immunization and nothing after the first shot. The night of the second shot (13Jan2021) patient had chills, fever, dizziness, headache, nausea, lack of appetite, fatigue, and hot flashes until the following two days (15Jan2021). Then dizziness, fatigue, nausea, lack of appetite, chills, and hot flashes for about a week (in Jan2021). No treatment for the adverse events. No covid prior vaccination. No covid tested post vaccination. The patient administered vaccine in Doctor's office/urgent care. The outcome of 'received first dose on 27dec2020 and second dose on 13jan2021' was unknown, of other events was recovered.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Soreness at injection site; tiredness; achiness; slight fever 99.2 degrees; This is a spontaneous report from a contactable consumer(patient) . A 72-year-old male patient received the second dose of BNT162B2 (lot number: EL9262), via an unspecified route of administration in left arm, on 05Feb2021 15:00 at single dose for COVID-19 immunisation. The patient's medical history was none. Concomitant medications were not reported. The patient had previously received the 1st dose of BNT162B2(Lot number: EL3246) on 15Jan2021 03:00 PM in left arm for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient was not tested for COVID-19. No known allergies. No other vaccines were received within 4 weeks. The patient experienced soreness at injection site, tiredness, achiness, slight fever 99.2 degrees on 06Feb2021. No treatment was received for the event. The patient underwent lab test included body temperature: 99.2 degrees on 06Feb2021. The outcome of the events was recovering.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Flushing, Hypersomnia, Pain in extremity
Clinical narrative: sore arm; slept for 17 straight hours; chills; upset stomach; upper body flushing for up to 4 days later; This is a spontaneous report from a contactable consumer (patient). A 54-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 16Jan2021 08:00 at single dose for COVID-19 immunization. Medical history included Known allergies to Possible latex, Diabetes, sleep apnea, PTSD (Post-traumatic stress disorder)/anxiety, herpes, vitamin d deficiency, environmental allergies, asthma. Concomitant medication was unspecified medication in two weeks. On 16Jan2021 08:00, The patient experienced sore arm, slept for 17 straight hours, chills, upset stomach, upper body flushing for up to 4 days later. Treatment received for the events included OTC medications. The patient was not pregnant. She had no COVID tested post vaccination. There was no other vaccine received in four weeks. The outcome of the events was recovered in 2021.   information on the lot/batch number has been requested.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: my heart beating fast/the pulse reading 170; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female patient received first dose bnt162b2 (PFIZER COVID 19 VACCINE, Lot number unknown), via an unspecified route of administration in the right arm on 05Feb2021 15:00 at SINGLE DOSE for covid-19 immunisation.  Medical history included arthritis and Penicillin Allergies.  The patient was not pregnant. The patient did not receive other vaccine on the same date and in four weeks. The patient's concomitant medications were unspecified other medication in two weeks.  Yesterday (05Feb2021) the patient received her first dose of Covid-19 vaccine at (vaccine facility name) around 3PM. They had everyone wait in the observation room for 15 minutes after the shot. She was fine during that time. In the evening around 8PM she noticed that her heart beating fast. A home use Oximeter showed the pulse reading 170 around 10PM. An hour later it went down to 105. This morning it came down to 84. She slept well last night. Her next appointment for the second dose is on 26Feb2021. Ae resulted in [None of the above]. The patient did not receive treatment for adverse event. The patient did not have COVID prior vaccination. The patient did not have COVID tested post vaccination. This event was non-serious and did not result in death and cause/prolong hospitalization, was not life threatening, Disabling/Incapacitating, Congenital anomaly/birth defect. Facility type Vaccine was Hospital.  The outcome of the event was recovered on 06Feb2021.  Information on the lot/batch number has been requested.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Fever; feeling unwell; muscle pain; chills; injection site pain; This is a spontaneous report from a contactable consumer (patient). An 82-year-old female patient (not pregnant) received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EN5318) via an unspecified route of administration in right arm on 05Feb2021 17:15 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took bacitracin and experienced allergies, nalidixic acid and experienced allergies. The patient experienced fever, feeling unwell, muscle pain, chills, injection site pain, all in Feb2021. No treatment received. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The outcome of the events was not recovered.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Orchitis, Orchitis noninfective
Clinical narrative: inflamed testicle; testicle infection/ got an infection in the testicles; This is a spontaneous report from a contactable consumer (patient). A 74-years-old male patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231) , via an unspecified route of administration on 21Jan2021 15:00 at single dose left arm for covid-19 immunisation.  Medical history included ongoing inflamed testicle, H blood pressure.  Concomitant medication included apixaban (ELIQUIS), venlafaxine, carvedilol, terazosin, lisinopril.  The patient was getting ready to take second shot on 14Feb2021, on 04Feb2021 patient started Sulfamethoxazole-TMP Ds Tablets for inflamed testicle. The patient had first shot of the COVID and did not have any problem. Since then patient got an infection in the testicles and then gave antibiotics (treatment) for the 4th of this month. So, the patient had 2, 3 doses of it. The patient was due to have second COVID shot on 14Feb2021 and patient am just trying to find out if patient should stop the antibiotics.  The outcome of events was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Pain
Clinical narrative: Fatigue; body aches; headache; general malaise; This is a spontaneous report from a consumer (patient). A 66-year-old female patient received first dose of BNT162B2 (lot/batch number and expiration date were unknown) via an unspecified route of administration at left arm on 05Feb2021 13:30 at single dose for COVID-19 immunisation. Medical history included idiopathic hypertrophic subaortic stenosis (IHSS). Unspecified concomitant medication used in two weeks. There was no known allergies. There was no other vaccine in four weeks. Patient did not have COVID prior vaccination. Patient was not pregnant. The patient had fatigue, body aches, headache and general malaise on 06Feb2021 at 08:00 a.m. Patient did not receive any treatment for events. She did not have COVID tested post vaccination. The outcome of events was recovering.  Information on batch number has been requested.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Pt experienced lymph node swelling in arm that injection was given; This is a spontaneous report from a non-contactable pharmacist. A 31-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246), intramuscular on arm on 08Jan2021 at SINGLE DOSE for covid-19 immunisation. Medical history included allergies to sulfa. Concomitant medication included montelukast sodium (SINGULAIR), cetirizine hydrochloride (ZYTREC), and birth control. The patient experienced lymph node swelling in arm that injection was given on 09Jan2021 with outcome of recovered. The patient received the 2nd dose of the vaccine with no issue.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Pain, Pain assessment, Tenderness, Vaccination site pain
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at left arm on 05Feb2021 08:30 at the age of 50-years-old at single dose for COVID-19 immunization. Medical history included obesity, inflammatory lung disease. No known allergies. The patient's concomitant medications were not reported. The historical vaccine included BNT162B2 on 15Jan2021 at the age of 50-years-old for COVID-19 immunization. The patient experienced 6 out of 10 pain, tenderness and mass of some sort behind left collarbone pain radiating toward shoulder and neck, injection site minimally sore on 05Feb2021 20:00. Pain resolves with ibuprofen, no treatment received for the other events. The events outcome was not recovered. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19. Information on the lot/batch number has been requested.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Urticaria
Clinical narrative: This is a spontaneous report from a contactable Consumer(patient). This consumer reported similar events for the patient. This is the first of two reports. A 67-year-old female patient received first dose BNT162B2 (Pfizer BioNTech Covid 19 vaccine), via an unspecified route of administration at Arm Right on 14-JAN-2021 at the 67 years old at single dose for COVID-19 immunization.  The medical history included breast cancer survivor, allergies to strawberries, bananas, lobster, mahi, whiting fish. The concomitant medications were cholecalciferol (VITAMIN D), ascorbic acid(VITAMIN C), collagen, curcuma longa(TURMERIC) , olive oil.  The patient previously took VALIUM and experienced allergy. The patient got hives near her left eye with the first Pfizer shot in 2021 but wasn't sure if that was the cause as she did have food allergies. Her arm was a little stiff but not significantly and she did not have any other side effects in 2021. There was not treatment received for all the events. The patient had no Covid prior vaccination. There was no Covid tested post vaccination.  The outcome of the events was recovered in 2021. The information on the batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021148988 same patient, same product( different dose), similar events
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nausea for 4 days to this point, individual "is never nauseous" and has been since the vaccine; This is a spontaneous report from a contactable consumer. A 75-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 02Feb2021 at single dose for COVID-19 immunisation. Medical history included thyroid imbalance, high blood pressure. The patient had no known allergies. No other vaccine was received in four weeks. No COVID prior vaccination. The patient's concomitant medications were not reported. The patient experienced nausea for 4 days to this point, she "is never nauseous" and had been since the vaccine on 02Feb2021. No treatment was received for event. No COVID tested post vaccination. The outcome of event was not recovered.  Information on lot/batch has been requested.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Pain assessment
Clinical narrative: Swollen lymph node in left arm pit pain 3/10; Swollen lymph node in left arm pit pain 3/10; This is a spontaneous report from a contactable consumer (patient). A 37-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=El9264), via an unspecified route of administration on left arm on 05Feb2021 15:00 (at age of 37 years old) at single dose for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient previously received his first dose of BNT162B2 (lot number=El3302) on left arm on 15Jan2021 01:00 PM for COVID-19 immunization. The patient experienced swollen lymph node in left arm pit pain 3/10 on 06Feb2021. The outcome of events was not recovered.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chillblains, Chills, Fatigue, Myalgia
Clinical narrative: Chilblain's of all 10 fingers. Onset 32 hours post vaccine./ Chilblains persist now 86 hours s/p vaccine; Fatigue; myalgia's; chills; This is a spontaneous report from a contactable physician reporting for herself.  A 41-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9264), intramuscularly on 03Feb2021 09:00 on left arm at single dose for COVID-19 immunization. Facility type vaccine was at Public Health Clinic/ facility. Medical history included gluten intolerance, known allergies: Penicillin, latex, suspect that she had COVID-19 in Feb2020. Concomitant medications included estradiol (DIVIGEL), progesterone (PROMETRIUM). The patient experienced Chilblain's of all 10 fingers, fatigue, myalgia's, chills, all on 04Feb2021 23:00. Chilblains persist now 86 hours s/p vaccine. No treatment was received for the events. The outcome of the events were not resolved.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Malaise, Nausea, Pain, Pain assessment
Clinical narrative: nausea; General malaise; diarrhea; localized pain 3-4/10; This is a spontaneous report from a contactable nurse (patient). The nurse reported 2 reports for same patient, same product. This is the first report. A 39-years-old female patient (not pregnant) received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ej1685), intramuscular at arm left on 22Dec2020 at the age of 39-years-old at single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included VITAMIN B complex (B COMPLEX), collagen marine, methylsulfonylmethane (MARINE COLLAGEN PEPTIDES WITH MSM), saw palmetto [serenoa repens] and zinc. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had allergies to Tramadol and Lexapro. The patient experienced general malaise with nausea and diarrhea, localized pain 3-4/10 after first dose on 22Dec2020 for 5 days (as reported). Therapeutic measures were taken as a result of general malaise with adverse event included antihistamine (as reported). The events outcome was recovering. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021148928 same patient, same product (second dose), different events with time gap
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: after about 5-6 hrs left side of my face became partially numb/feels like a hand is on my face/ Now been 4 days and still somewhat numb; This is a spontaneous report from a contactable consumer (patient). A 67-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on left arm on 03Feb2021 09:00 am at SINGLE DOSE for covid-19 immunisation.  Medical history included sjogren's syndrome, allergies to sulfa.  The patient's concomitant medications were not reported. It is reported on 03Feb2021 02:00 PM, about 5-6 hours after the vaccination, left side of patient face became partially numb. Everything functions fine but feels like a hand is on her face. Went to doctor who couldn't find anything else wrong and encouraged her to still get second shot. Now been 4 days and still somewhat numb, possible getting better but hard to tell. No treatment received for the events. Outcome of the event was not recovered. The patient is not pregnant. No covid prior vaccination. No covid tested post vaccination.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vaccination site paraesthesia
Clinical narrative: Started as localized tingling/pins and needle sensation by injection site approximately 4 hours after initial injection.; the sensation spread to all extremities (arms, hands, legs, and feet).; This is a spontaneous report from a contactable consumer (patient). This 27-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL3247) via an unspecified route of administration on 17Jan2021 at 15:00 (at the age of 27-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was not reported. The patient was not pregnant at the time of vaccination. It was unknown if the patient had COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient did not receive any concomitant medications. The patient previously received cefprozil (CEFZIL) and vancomycin from unknown dates and experienced allergy. On 17Jan2021 at 19:00, the patient experienced localized tingling/pins and needle sensation by the injection site approximately 4 hours after initial injection. Over the course of the next day the sensation spread to all extremities (arms, hands, legs, and feet). It was three weeks since first dose and sensation had lessened but still felt at times. The patient did not receive any treatment for the events. The outcome of tingling by the injection site and sensation spread to all extremities was not recovered. It was also reported the patient had not been tested for COVID-19 since the vaccine.   No follow-up attempts are needed. No further information is expected.